Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from IMC

Is the US sending $50m in condoms to Gaza as Trump claims?

The US president has listed the stopping of condoms to Gaza as an accomplishment. But is he thinking of the wrong Gaza?

Al Jazeera

Intel Panther Lake will allegedly reintegrate the memory controller into the compute tile — Nova Lake is expected to separate the two again with added optimizations

Intel is rumored to combine the IMC and cores in a single tile with Panther Lake but separate them again in Nova Lake.

Tom’s Hardware

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

India Mobile Congress 2023 | 2014 is not a date, but a change, says PM Modi

PM Modi inaugurated 7th India Mobile Congress, showcasing tech like 5G Plus, AI-enabled tech, and other Digital infrastructure. IMC 2023 seeks to reinforce India's position as a developer, manufacturer, and exporter of cutting-edge tech. IMC introduces 'Aspire' program to facilitate connections between startups, investors, and established businesses. Event to host…

The Hindu

High drug prices in Canada are just one side of a bad equation

The Canadian health-care system is under pressure as service levels decline while costs escalate. Drugs are one of our largest health-care expenditures. A federal agency, the Patented Medicine Prices Review Board (PMPRB), is supposed to control drug prices for Canadians.

The Conversation

2 Cannabis Stocks Not Worth the Smoke

Despite its remarkable growth during the pandemic, the cannabis industry's current trajectory has been marred by legal, economic, and sector-wide hurdles. This has cast a pall over the industry’s outlook. Therefore, fundamentally weak stocks Aurora Cannabis (ACB) and IM Cannabis (IMCC) might be avoided now. Continue reading….

StockNews.com

Egypt Tackles Saudi Investors Problems in Real Estate, Industrial Projects

Egyptian Prime Minister Mostafa Madbouly stressed the importance his government attaches to solving problems that local and foreign investors face, as well as creating a more attractive climate for investments in the country. In remarks during a meeting with a group of Saudi investors in Egypt on Tuesday, Madbouly said…

Asharq Al-Awsat

Read news from The Economist, FT, and more,
with one subscription

How the pharmaceutical industry uses disinformation to undermine drug price reform

Canada’s drug prices are the fourth highest in the developed world. Despite this, Innovative Medicines Canada (IMC), the lobby group for Big Pharma, put out a call in November 2022 for the Canadian government to suspend consultations on guidelines aimed at lowering prescription drug prices.

The Conversation

M.P. HC directs government to give 'reasoned and speaking order' in pension scam case involving BJP leader Vijayvargiya

The HC also directed the complainant to file a fresh application for getting the prosecution sanction against the leader

The Hindu

PM likely to launch 5G services on October 1

NEW DELHI:

The Hindu

IM Cannabis Q2 Revenue Grows 114% YoY, What About Profit?

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for its second quarter ended June 30, 2022, revealing revenues increased 114% year-over-year to CA$23.8 million ($18.43 million). Q2 2022 Financial Results

Benzinga

Hamburg Launched Partnership To Ease the Burden On Medical Marijuana Patients And Doctors

By Oren Shuster The project, known as “Pain Initiative Cannabinoids 2021”, is a crucial development in advancing the German cannabis industry

Benzinga

Former Omagh cinema site goes on the market

The IMC Cinema on the Gillygooley Road in Omagh ceased trading in April

Belfast Live

IM Cannabis Reports Record First Quarter 2022 Financial Results, Revenues Increase 169% YoY To $23.6M

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical and adult-use cannabis company with operations in Israel, Canada, and Germany, announced its financial results on Thursday for the three months ended March 31, 2022 (Q1).

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

IM Cannabis Revenue In 2021 Grows 242% to $43.38M

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) released financial results for the three months and fiscal year ended December 31, 2021.

Benzinga

IM Cannabis Closes Acquisition Of Israel's Medical Marijuana Oranim Pharm

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) has completed the strategic acquisition of 51% of the rights in Oranim Pharm partnership, a pharmacy selling medical cannabis in Israel. The acquisition was completed through IMC Holdings Ltd., a wholly-owned subsidiary of IM Cannabis Corp., following receipt of all requisite approvals, including from the Israeli Medical…

Benzinga

IM Cannabis Closes Three Strategic Acquisitions In Israel Valued Around $11.77M

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) has completed three strategic acquisitions.

Benzinga

IM Cannabis Q4 Revenues To Increase 308% YoY, Positioned To Capture Market Growth In Israel

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) has reported its preliminary unaudited financial results for the three months and fiscal year ended December 31, 2021.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

MediCane Health Receives IMC-GMP License For Its Manufacturing Plant In Israel

Cannabis-focused pharmaceutical company MediCane Health Inc. announced the awarding of an IMC-GMP license for its new manufacturing facility in Kfar Saba, Israel. The approval received this month will enable MediCane to manufacture dry herb and cannabis-based oils, as well as to produce novel formulations for its in-house

The Conversation

Lower drug prices are a priority for Canadians, but not for the federal government

Once again, the federal minister of health has postponed changes to the Patented Medicine Prices Review Board (PMPRB) regulations for another six months until July 1, 2022.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.